Question 1

Is (see Schedule O) a tax-exempt 501(c)(3)?

Accepted Answer

Yes — (see Schedule O) is recognised by the IRS as a 501(c)(3) organisation (EIN 26-4340897). The IRS recognised (see Schedule O) as tax-exempt in April 2009.

Question 2

What is (see Schedule O)'s EIN?

Accepted Answer

(see Schedule O)'s Employer Identification Number (EIN) is 26-4340897. The EIN was assigned by the IRS in April 2009. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.

Question 3

What does (see Schedule O) do?

Accepted Answer

To promote the awareness, education, research, and treatment of prostate cancer.

Question 4

Where is (see Schedule O) located?

Accepted Answer

(see Schedule O) is located at 419 Golf View Lane, Rochester, MI, 48309.

Question 5

When was (see Schedule O) founded or recognised by the IRS?

Accepted Answer

(see Schedule O) was recognised by the IRS as a tax-exempt organisation in April 2009. The IRS ruling date is the earliest authoritative date available for most US nonprofits.

Question 6

What is (see Schedule O)'s annual revenue?

Accepted Answer

On its most recent Form 990 (fiscal year 2024), (see Schedule O) reported $300K in total revenue and $284K in total expenses.

Question 7

Has (see Schedule O) been auto-revoked by the IRS?

Accepted Answer

No — (see Schedule O) (EIN 26-4340897) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.

Question 8

Is (see Schedule O) listed in IRS Publication 78?

Accepted Answer

Yes — (see Schedule O) is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.

Loading profile…

(see Schedule O)

Due Diligence Summary

AI Organization Overview

Mission Statement

Organization Details

Contact

Financial Snapshot

Location

Governance

Frequently asked questions about (see Schedule O)